Low-Dose Lenalidomide After Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation With Bortezomib as Graft-Versus-Host Disease Prophylaxis in High-Risk Multiple Myeloma.
暂无分享，去创建一个
M. Kalaycio | B. Hill | A. Gerds | B. Pohlman | R. Sobecks | R. Dean | B. Bolwell | F. Reu | Donna Corrigan | B. Hamilton | N. Majhail | D. Jagadeesh | Hien D. Liu | J. Khouri